文献速递心血管MR

功能与特征追踪心脏MRI参数在预测地中海贫血患者不良心脏事件及心源性死亡中的重要性

The Importance of Functional and Feature-Tracking Cardiac MRI Parameters in Prediction of Adverse Cardiac Events and Cardiac Mortality in Thalassemia Patients.
PubMed 文献 · Acad Radiol · 2022-02-04

本研究纳入159例重型地中海贫血患者,随访8–64个月(中位36个月),评估CMR来源的功能、特征追踪及T2*参数对不良心脏事件(ACE)及心源性死亡的预测价值。17例(10.7%)发生ACE;右心室射血分数(RVEF)是ACE和心源性死亡的最强预测指标,RV整体纵向应变(GLS)是最强应变参数,心肌T2*可预测死亡。

要点

  • RVEF是ACE和心源性死亡的最强预测指标(OR分别为0.85和0.88)。
  • RV GLS是预测ACE和死亡的最强应变参数(OR均为0.81)。
  • 心肌T2*可预测心源性死亡(OR 0.90),T2*≤10 ms预测死亡的敏感度85.71%、特异度85.91%。

核心结论

  • 特征追踪及非对比增强CMR参数是地中海贫血患者不良心脏事件的有价值标志物。

研究设计与样本

  • 研究纳入159例重型地中海贫血患者(女性49.7%,平均年龄32±9.8岁),随访8–64个月(中位36个月),记录CMR来源的功能、特征追踪及T2*参数以及不良心脏事件。

诊断标准与关键数值

  • RVEF≤39%预测ACE,敏感度62.5%,特异度95.77%。
  • RVEF≤37%预测心源性死亡,敏感度71.43%,特异度93.38%。
  • 心肌T2*≤10 ms预测死亡,敏感度85.71%,特异度85.91%。
  • RV GLS≤16.43%预测ACE,敏感度52.94%,特异度90%。
  • RV GLS≤15.63%预测死亡,敏感度71.43%,特异度90%。

临床应用与阅片要点

  • RVEF是ACE和心源性死亡的最强预测指标(OR 0.85,95%CI 0.790–0.918,p<0.001;OR 0.88,95%CI 0.811–0.973,p=0.01)。
  • RV GLS是预测ACE和死亡的最强应变参数(OR 0.81,95%CI 0.740–0.902,p<0.001;OR 0.81,95%CI 0.719–0.933,p=0.003)。
  • 心肌T2*可预测心源性死亡(OR 0.90,95%CI 0.814–0.999,p=0.04)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Despite some investigations about the role of cardiovascular magnetic resonance (CMR) imaging in thalassemia, there are a few studies regarding the feature-tracking (FT). We evaluated the role of T2*, functional, and FT values for the determining of adverse cardiac events (ACE).

METHODS: One-hundred-fifty-nine patients with thalassemia-major (49.7% female, mean-age = 32 ± 9.8 year) were followed for 8 - 64 (median = 36) months. CMR derived functional, FT, and T2* as well as ACE (heart failure hospitalization, cardiac mortality, pulmonary hypertension, and arrhythmias) were recorded. Also, variables were analyzed for cardiac death prediction separately.

RESULTS: Seventeen patients (10.7%) developed ACE. The right-ventricular ejection fraction (RVEF) was the strongest indicator of ACE (OR: 0.85, 95% - CI: 0.790 - 0.918; p < 0.001) and cardiac mortality (OR: 0.88, 95%-CI: 0.811 - 0.973; p = 0.01). RVEF ≤ 39% and ≤ 37% predicted ACE and mortality with sensitivity of 62.5% and 71.43% and specificity of 95.77% and 93.38%, respectively. Additionally, myocardial-T2* was a predictor of mortality (OR: 0.90, 95%-CI: 0.814 - 0.999; p = 0.04). T2* ≤ 10 months predicted death with 85.71% sensitivity and 85.91% specificity. RV global longitudinal strain (GLS) was the strongest strain parameter for the indication of ACE and death (OR: 0.81, 95%-CI: 0.740 - 0.902; p < 0.001 and OR: 0.81, 95%- CI: 0.719 - 0.933; p = 0.003, respectively). RV GLS ≤ 16.43% and ≤ 15.63% determined ACE and death with sensitivity of 52.94% and 71.43% and specificity of 90%, respectively.

CONCLUSION: Our results underscore the role of FT and non-contrast CMR parameters as valuable markers of ACE in thalassemia.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Asadian, Hosseini, Rezaeian, et al. The Importance of Functional and Feature-Tracking Cardiac MRI Parameters in Prediction of Adverse Cardiac Events and Cardiac Mortality in Thalassemia Patients. Acad Radiol. 2022. PMID: 35131148. doi:10.1016/j.acra.2022.01.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。